The Perrigo Company Charitable Foundation is proud to announce the donation of a total of $75,000 to Wings of Hope Hospice and Wings Home.
Perrigo Company plc (NYSE; TASE: PRGO) announced today that it has completed the acquisition of the branded over-the-counter (OTC) rights to Prevacid®24HR.
As an early Thanksgiving gift Perrigo is proud to announce the donation of a Perrigo building appraised at $320,000 to Safe Harbor in Allegan, Michigan. Perrigo held a ceremony to present the keys in honor of the the transition of the building ownership to Safe Harbor Children’s Advocacy Center.
Perrigo Company plc (NYSE; TASE: PRGO) announced that its “Quitting is Better” nicotine replacement therapy campaign has won a notable national award for the Best OTC Corporate Social Responsibility Campaign.
DUBLIN, Nov. 6, 2019 -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of "Quality, Affordable Self-Care ProductsTM", today announced financial results for the third quarter ended September 28, 2019.
Perrigo scientists gave a ‘big’ science lesson to West Michigan families when they unveiled the world’s largest periodic table on Saturday. Officials from the Guinness Book of World Records were present to judge the feat.
Perrigo Company plc (NYSE; TASE: PRGO) announced that its “Quitting is Better” nicotine replacement therapy campaign has earned national recognition from the Consumer Healthcare Products Association (CHPA) Educational Foundation for innovation and strategic marketing in the consumer healthcare products industry.
Upon receiving communication from the U.S. Food and Drug Administration (FDA) regarding the potential for presence of N-nitrosodimethylamine (NDMA) in certain ranitidine-based products, Perrigo Company plc promptly initiated testing of its externally sourced ranitidine API and ranitidine-based products.
The Perrigo Charitable Foundation and Perrigo employees have joined together to help victims of Hurricane Dorian both within the U.S. and internationally. Hurricane Dorian impacted multiple southeast states, the Caribbean, and the Bahamas as it made landfall last week.
Perrigo Company plc (NYSE; TASE: PRGO) announced today that it has entered into a definitive agreement to acquire the branded OTC rights to Prevacid® from GlaxoSmithKline.